OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
Fred Cohen, Hsiangkuo Yuan, Ellen Michelle Gibson DePoy, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 922-930
Open Access | Times Cited: 23
Fred Cohen, Hsiangkuo Yuan, Ellen Michelle Gibson DePoy, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 922-930
Open Access | Times Cited: 23
Showing 23 citing articles:
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
Albert Muñoz‐Vendrell, Sergio Campoy, Edoardo Caronna, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 28
Albert Muñoz‐Vendrell, Sergio Campoy, Edoardo Caronna, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 28
The Registry for Migraine (REFORM) study: methodology, demographics, and baseline clinical characteristics
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 18
William Kristian Karlsson, Håkan Ashina, Christopher Kjær Cullum, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 18
Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the rat
Nadine Friedrich, Krisztína Németh, Martin Tanner, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Nadine Friedrich, Krisztína Németh, Martin Tanner, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Effect of anti‐CGRP ‐targeted therapy on migraine aura: Results of an observational case series study
Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 4
Elena Cresta, Alessia Bellotti, Giovanni Rinaldi, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 2
Open Access | Times Cited: 4
Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics
Lanfranco Pellesi, Thien Phu, Martin Ernst, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Lanfranco Pellesi, Thien Phu, Martin Ernst, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Preventive CGRP-targeted therapies for chronic migraine with and without medication-overuse headache
Alicia Alpuente, Marta Torres‐Ferrús, Gisela M. Terwindt
Cephalalgia (2023) Vol. 43, Iss. 3
Open Access | Times Cited: 9
Alicia Alpuente, Marta Torres‐Ferrús, Gisela M. Terwindt
Cephalalgia (2023) Vol. 43, Iss. 3
Open Access | Times Cited: 9
Mechanisms and treatments of chronic pain after traumatic brain injury
QiLiang Chen, Vimala N. Bharadwaj, Karen‐Amanda Irvine, et al.
Neurochemistry International (2023) Vol. 171, pp. 105630-105630
Closed Access | Times Cited: 9
QiLiang Chen, Vimala N. Bharadwaj, Karen‐Amanda Irvine, et al.
Neurochemistry International (2023) Vol. 171, pp. 105630-105630
Closed Access | Times Cited: 9
No causal association between allergic rhinitis and migraine: a Mendelian randomization study
Hao Lv, Kunyu Liu, Yulie Xie, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Hao Lv, Kunyu Liu, Yulie Xie, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 2
Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections
Fernando de Mora, Karl Meßlinger
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103941-103941
Open Access | Times Cited: 2
Fernando de Mora, Karl Meßlinger
Drug Discovery Today (2024) Vol. 29, Iss. 4, pp. 103941-103941
Open Access | Times Cited: 2
Anti-calcitonin Gene-Related Peptide Monoclonal Antibodies in Migraine: Focus on Clinical Pharmacokinetics
Slobodan Јаnkovic, Snežana V. Janković
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 3, pp. 277-293
Closed Access | Times Cited: 2
Slobodan Јаnkovic, Snežana V. Janković
European Journal of Drug Metabolism and Pharmacokinetics (2024) Vol. 49, Iss. 3, pp. 277-293
Closed Access | Times Cited: 2
Filling the data gap on CGRP mAb therapy in low- to middle-income countries in Southeast Asia: insights from a real-world study in Thailand
Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Prakit Anukoolwittaya, Akarin Hiransuthikul, Thanakit Pongpitakmetha, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Emerging experimental drugs in clinical trials for migraine: observations and key talking points
William David Wells-Gatnik, Tiffany Y. Wences Chirino, Fatma Nur Onan, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 761-771
Closed Access | Times Cited: 5
William David Wells-Gatnik, Tiffany Y. Wences Chirino, Fatma Nur Onan, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 8, pp. 761-771
Closed Access | Times Cited: 5
Consensus-Based Recommendations on the Use of CGRP-Based Therapies for Migraine Prevention in the UAE
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Taoufik Alsaadi, Deeb Maxwell Kayed, Abubaker Almadani, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1845-1865
Open Access | Times Cited: 5
Monoclonal antibodies targeting the calcitonin gene-related peptide pathway improve the effectiveness of acute medication—a real-world study
Chiara Rosignoli, Valeria Caponnetto, Agnese Onofri, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 3305-3312
Open Access | Times Cited: 1
Chiara Rosignoli, Valeria Caponnetto, Agnese Onofri, et al.
Neurological Sciences (2024) Vol. 45, Iss. 7, pp. 3305-3312
Open Access | Times Cited: 1
Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache
Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, et al.
Confinia Cephalalgica (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, et al.
Confinia Cephalalgica (2024) Vol. 34, Iss. 1
Open Access | Times Cited: 1
Research trends and hotspots in clinical trials of migraine in the past 20 years: bibliometric analysis
Xiaoxin Wang, Yan Sun, Yuan Zhang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Xiaoxin Wang, Yan Sun, Yuan Zhang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab
Haidar Muhsen Al-Khazali, Håkan Ashina, Rune Häckert Christensen, et al.
Cephalalgia (2024) Vol. 44, Iss. 6
Open Access
Haidar Muhsen Al-Khazali, Håkan Ashina, Rune Häckert Christensen, et al.
Cephalalgia (2024) Vol. 44, Iss. 6
Open Access
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling
Mokshada Kumar, Sravani Lanke, Alka Yadav, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 54-54
Open Access
Mokshada Kumar, Sravani Lanke, Alka Yadav, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 54-54
Open Access
Botulinum Toxin and Migraine: Goals and Perspectives
Maria Pia Prudenzano
Toxins (2024) Vol. 16, Iss. 12, pp. 530-530
Open Access
Maria Pia Prudenzano
Toxins (2024) Vol. 16, Iss. 12, pp. 530-530
Open Access
Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies
Marinos C. Dalakas, Heinz Wiendl
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 687-690
Open Access | Times Cited: 2
Marinos C. Dalakas, Heinz Wiendl
Neurotherapeutics (2022) Vol. 19, Iss. 3, pp. 687-690
Open Access | Times Cited: 2
Migräne - Diagnostik und Prophylaxe
Elizabeth George, Andreas Straube, Katharina Kamm
MMW - Fortschritte der Medizin (2023) Vol. 165, Iss. 17, pp. 52-58
Closed Access
Elizabeth George, Andreas Straube, Katharina Kamm
MMW - Fortschritte der Medizin (2023) Vol. 165, Iss. 17, pp. 52-58
Closed Access
Preface
Hari Shanker Sharma, Lars Wiklund, Aruna Sharma
International review of neurobiology (2023), pp. xvii-xxii
Closed Access
Hari Shanker Sharma, Lars Wiklund, Aruna Sharma
International review of neurobiology (2023), pp. xvii-xxii
Closed Access
The Most Promising Targeted Preparation for the Treatment of Migraine from the Pathophysiological Mechanism: Aimed at CGRP Drugs
Xinyi Cui, Hai Lin
MEDS Basic Medicine (2023) Vol. 1, Iss. 3
Open Access
Xinyi Cui, Hai Lin
MEDS Basic Medicine (2023) Vol. 1, Iss. 3
Open Access
The Most Promising Targeted Preparation for the Treatment of Migraine from the Pathophysiological Mechanism: Aimed at CGRP Drugs
Xinyi Cui, Hai Lin
MEDS Basic Medicine (2023) Vol. 1, Iss. 2
Open Access
Xinyi Cui, Hai Lin
MEDS Basic Medicine (2023) Vol. 1, Iss. 2
Open Access
